TCR2 Therapeutics Inc. Share Holder Equity 2019-2023 | TCRR
TCR2 Therapeutics Inc. share holder equity from 2019 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
| TCR2 Therapeutics Inc. Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2022 | $141 |
| 2021 | $281 |
| 2020 | $237 |
| 2019 | $160 |
| 2018 | $124 |
| 2017 | $21 |
| 2016 | $17 |
| TCR2 Therapeutics Inc. Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023-03-31 | $101 |
| 2022-12-31 | $141 |
| 2022-09-30 | $199 |
| 2022-06-30 | $226 |
| 2022-03-31 | $255 |
| 2021-12-31 | $281 |
| 2021-09-30 | $306 |
| 2021-06-30 | $329 |
| 2021-03-31 | $350 |
| 2020-12-31 | $237 |
| 2020-09-30 | $252 |
| 2020-06-30 | $133 |
| 2020-03-31 | $147 |
| 2019-12-31 | $160 |
| 2019-09-30 | $171 |
| 2019-06-30 | $183 |
| 2019-03-31 | $192 |
| 2018-12-31 | $124 |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
